EPIX
Price
$0.24
Change
+$0.01 (+4.35%)
Updated
Aug 29, 03:56 PM (EDT)
Capitalization
11.12M
116 days until earnings call
NKTX
Price
$2.15
Change
-$0.06 (-2.73%)
Updated
Aug 29, 04:09 PM (EDT)
Capitalization
156.25M
68 days until earnings call
Interact to see
Advertisement

EPIX vs NKTX

Header iconEPIX vs NKTX Comparison
Open Charts EPIX vs NKTXBanner chart's image
ESSA Pharma
Price$0.24
Change+$0.01 (+4.35%)
Volume$2K
Capitalization11.12M
Nkarta
Price$2.15
Change-$0.06 (-2.73%)
Volume$200
Capitalization156.25M
EPIX vs NKTX Comparison Chart in %
Loading...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPIX vs. NKTX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPIX is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (EPIX: $0.23 vs. NKTX: $2.20)
Brand notoriety: EPIX and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPIX: 142% vs. NKTX: 67%
Market capitalization -- EPIX: $11.12M vs. NKTX: $156.25M
EPIX [@Biotechnology] is valued at $11.12M. NKTX’s [@Biotechnology] market capitalization is $156.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPIX’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • EPIX’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both EPIX and NKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPIX’s TA Score shows that 5 TA indicator(s) are bullish while NKTX’s TA Score has 3 bullish TA indicator(s).

  • EPIX’s TA Score: 5 bullish, 5 bearish.
  • NKTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EPIX is a better buy in the short-term than NKTX.

Price Growth

EPIX (@Biotechnology) experienced а -1.57% price change this week, while NKTX (@Biotechnology) price change was -5.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

EPIX is expected to report earnings on Dec 23, 2025.

NKTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($156M) has a higher market cap than EPIX($11.1M). EPIX YTD gains are higher at: 5.575 vs. NKTX (-11.647). EPIX has higher annual earnings (EBITDA): -23.52M vs. NKTX (-119.2M). NKTX has more cash in the bank: 290M vs. EPIX (45.9M). EPIX has less debt than NKTX: EPIX (280K) vs NKTX (78.5M). EPIX (0) and NKTX (0) have equivalent revenues.
EPIXNKTXEPIX / NKTX
Capitalization11.1M156M7%
EBITDA-23.52M-119.2M20%
Gain YTD5.575-11.647-48%
P/E RatioN/AN/A-
Revenue00-
Total Cash45.9M290M16%
Total Debt280K78.5M0%
FUNDAMENTALS RATINGS
EPIX: Fundamental Ratings
EPIX
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPIXNKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 5 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDORY3.940.16
+4.23%
Banco Do Brasil SA
NZRFF1.00N/A
N/A
CHANNEL INFRASTRUCTURE NZ LTD
CEHCF30.00N/A
N/A
Cosmo Energy Hldgs Co Ltd
SPAIF0.22N/A
N/A
Sparc AI Inc.
BLOZF0.40N/A
-0.96%
Cannabix Technologies Inc.

EPIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPIX has been loosely correlated with ELAB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if EPIX jumps, then ELAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPIX
1D Price
Change %
EPIX100%
-4.32%
ELAB - EPIX
47%
Loosely correlated
-6.03%
LXRX - EPIX
34%
Loosely correlated
+1.77%
PCVX - EPIX
31%
Poorly correlated
+0.72%
MREO - EPIX
27%
Poorly correlated
-0.57%
NKTX - EPIX
27%
Poorly correlated
-1.79%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-1.79%
BEAM - NKTX
49%
Loosely correlated
-0.06%
FATE - NKTX
49%
Loosely correlated
-3.57%
CRBU - NKTX
48%
Loosely correlated
-2.02%
SYRE - NKTX
47%
Loosely correlated
-2.45%
IMNM - NKTX
45%
Loosely correlated
-0.50%
More